司美格鲁肽注射液治疗2型糖尿病患者短期与长期经济学研究系统评价
Short/long-term economic evaluations of Semaglutide Injection for the treatment of patients with type 2 diabetes mellitus
保芸 1万旭 2吴斌 3俞萍萍 4王立群5
作者信息
- 1. 甘肃省人民医院临床循证医学研究所,甘肃兰州 730000
- 2. 上海交通大学医学院附属仁济医院药学部,上海 200000
- 3. 上海交通大学医学院附属仁济医院临床研究中心,上海 200000
- 4. 宁波市第二医院药学部,浙江宁波 315010
- 5. 首都医科大学附属北京安贞医院中医理疗科,北京 100000
- 折叠
摘要
目的:系统评价国内外司美格鲁肽注射液的短期和长期济学研究现状.方法:系统检索PubMed、Embase、Web of Science、Cochrane Library、EBM Reviews-Health Technology Assessment、EBM Reviews-NHS Economic Evaluation Database、中国知网、万方、维普9个数据库及ISPOR网站.检索时间从建库至2023年12月1日.2名研究者独立筛选文献、提取数据和评价质量后进行定性分析.结果:共纳入38篇文献,结果表明在相关研究国家视角下,与其他GLP-1受体激动剂(度拉糖肽、艾塞那肽ER、利拉鲁肽)及甘精胰岛素注射液相比,司美格鲁肽注射液具有经济性;与SGLT-2抑制剂(恩格列净和卡格列净)相比,司美格鲁肽注射液具有长期经济性.结论:仍需开展基于中国人群真实世界数据的各项经济学研究,为利益相关者提供决策依据.
Abstract
OBJECTIVE To systematically review the short/long-term economic evaluations of Semaglutide Injection.METHODS The databases of PubMed,Embase,Web of Science,Cochrane Library,EBM Reviews-Health Technology Assessment,EBM Reviews-NHS Economic Evaluation Database,China National Knowledge Infrastructure(CNKI),Wan-fang,VIP and ISPOR were searched from inception until December 1,2023.Two researchers independently screened reports,extracted raw data and evaluated qualities.RESULTS A total of 38 articles were included.From the perspective of research countries,Semaglutide Injection was economically advantageous compared to other GLP-1 receptor agonists(e.g.dulaglutide,exenatide ER & liraglutide)and insulin glargine.When compared with SGLT-2 inhibitors(empagliflozin &.canagliflozin),Sema-glutide Injection demonstrated superior long-term economic benefits.CONCLUSION Further economic studies based upon real-world data of Chinese populations are required for providing decision-making references for stakeholders.
关键词
司美格鲁肽注射液/控制成本分析/成本效果分析/系统评价Key words
Semaglutide Injection/cost control analysis/cost-effectiveness analysis/systematic review引用本文复制引用
基金项目
上海申康医院发展中心临床科技创新项目(SHDC12019X10)
兰州市城关区科技计划项目(2018KJGG0036)
出版年
2024
NETL
NSTL
万方数据